MENTAX Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Mentax, and when can generic versions of Mentax launch?

Mentax is a drug marketed by Mylan and is included in two NDAs.

The generic ingredient in MENTAX is butenafine hydrochloride. There are two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Mentax

A generic version of MENTAX was approved as butenafine hydrochloride by TARO on November 16^th, 2017.

Try a Trial

Summary for MENTAX

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	104
Patent Applications:	321
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for MENTAX
What excipients (inactive ingredients) are in MENTAX?	MENTAX excipients list
DailyMed Link:	MENTAX at DailyMed

Drug patent expirations by year for MENTAX

Anatomical Therapeutic Chemical (ATC) Classes for MENTAX

D01AE	Other antifungals for topical use
D01A	ANTIFUNGALS FOR TOPICAL USE
D01	ANTIFUNGALS FOR DERMATOLOGICAL USE
D	Dermatologicals

US Patents and Regulatory Information for MENTAX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	MENTAX	butenafine hydrochloride	CREAM;TOPICAL	020524-001	Oct 18, 1996		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Mylan	MENTAX-TC	butenafine hydrochloride	CREAM;TOPICAL	021408-001	Oct 17, 2002		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for MENTAX

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Mylan	MENTAX	butenafine hydrochloride	CREAM;TOPICAL	020524-001	Oct 18, 1996	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for MENTAX

See the table below for patents covering MENTAX around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Germany	3580401		⤷ Try a Trial
Hong Kong	111793	AMINE DERIVATIVES,PROCESSES FOR PREPARING THE SAME AND FUNGICIDES CONTAINING THE SAME	⤷ Try a Trial
Singapore	69893		⤷ Try a Trial
Canada	1334973	DERIVES AMINE, PROCEDES POUR LEUR PREPARATION ET FONGICIDES EN CONTENANT (AMINE DERIVATIVES, PROCESSES FOR PREPARING THE SAME AND FUNGICIDES CONTAINING THE SAME)	⤷ Try a Trial
South Korea	920005488		⤷ Try a Trial
Japan	H057382		⤷ Try a Trial
China	85104330		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for MENTAX

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0164697	91031	Luxembourg	⤷ Try a Trial	91031, EXPIRES: 20100606
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Summary for MENTAX

Anatomical Therapeutic Chemical (ATC) Classes for MENTAX

Make Better Decisions: Try a trial or see plans & pricing